[1]
A. Muskat, L. Hoffman, Y. Kost, D. M. Mattis, B. Amin, and B. N. McLellan, “A rare case of erythema dyschromicum perstans arising in the setting of a third-generation tyrosine kinase inhibitor”, AO, vol. 61, no. 7, pp. 830–832, Jul. 2022.